Clinical trial
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
NCT00417716 · Asociación para Evitar la Ceguera en México, Other · Withdrawn
Key facts
| NCT number | NCT00417716 |
|---|---|
| Title | Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema |
| Official title | The Efficacy of a Single Intravitreal Injection of Bevacizumab in Patients With Diffuse Diabetic Macular Edema |
| Lead sponsor | Asociación para Evitar la Ceguera en México, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2, Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Intravitreal Bevacizumab |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Jan 4, 2007 |
| Last update posted | Jun 3, 2024 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: